Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mazumdar

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancerW K Kelly, H I Scher, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trialD F Bajorin, J A McCaffrey, S Hilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.
The Journal of Urology|December 24, 1997
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumorsR J Motzer, A Amsterdam, V Prieto, et al.
Cancer Research|August 15, 1993
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumorsR J Motzer, S C Gulati, W P Tong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Measuring tumor response and shape change on CT: esophageal cancer as a paradigmL H Schwartz, J A C Colville, M S Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, H Herr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tractP M Dodd, J A McCaffrey, S Hilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer CenterH S Puc, R Heelan, M Mazumdar, et al.
Cancer|February 15, 1994
Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival updateN Kemeny, K Seiter, J A Conti, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1995
Suramin and hydrocortisone: determining drug efficacy in androgen-independent prostate cancerW K Kelly, H I Scher, M Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Treatment of patients with transitional-cell carcinoma of the urothelial tract with ifosfamide, paclitaxel, and cisplatin: a phase II trialD F Bajorin, J A McCaffrey, S Hilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Phase II randomized trial of gallium nitrate plus fluorouracil versus methotrexate, vinblastine, doxorubicin, and cisplatin in patients with advanced transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.
The Journal of Urology|December 24, 1997
Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumorsR J Motzer, A Amsterdam, V Prieto, et al.
Cancer Research|August 15, 1993
Phase I trial with pharmacokinetic analyses of high-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in patients with refractory germ cell tumorsR J Motzer, S C Gulati, W P Tong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2006
Measuring tumor response and shape change on CT: esophageal cancer as a paradigmL H Schwartz, J A C Colville, M S Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinomaP M Dodd, J A McCaffrey, H Herr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tractP M Dodd, J A McCaffrey, S Hilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer CenterH S Puc, R Heelan, M Mazumdar, et al.
Cancer|February 15, 1994
Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival updateN Kemeny, K Seiter, J A Conti, et al.
Pageof 11